Osteoporosis | The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
Osteoporosis research study
What is the primary objective of this study?
To determine whether administration of Alendronate early is more effective than late in the
prevention of osteoporosis following a hip fracture
Who is eligible to participate?
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Start Date: January 2003
Completed Date: April 2007
Phase: Phase 3
Study sponsors, principal investigator, and references
Principal Investigator: Richard Kremer, MD PhD
Lead Sponsor: McGill University Health Center
Collaborator: Merck Frosst Canada Ltd.